Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Toll-like receptor 3 (TLR3) stimulation in the treatment of cancer

Outputs and Outcomes

Code

365L5609

Duration

01 January 2010 → 31 December 2010

Funding

Funding by bilateral agreement (private and foundations)

Promotor

Rudi Beyaert

Research disciplines

Natural sciences
- Biochemistry and metabolism
- Systems biology
Medical and health sciences
- Immunology
- Medical biochemistry and metabolism
- Immunology
- Medical biochemistry and metabolism
- Immunology
- Medical biochemistry and metabolism

Keywords

signal transduction TLR3 cancer

Project description

TLR3 stimulation is potentially important in the treatment of cancer. It has the potential to increase the efficiency of anti-cancer vaccines, and is also directly cytotoxic for tumor cells. In this project we study TLR3-induced signal transduction and mechanisms responsible for TLR3 resistance.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by